MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1086/597477

Медицинская библиотека · The Journal of infectious diseases · 2009

Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings.

Ajzenberg Daniel, Yera Hélène, Marty Pierre, Paris Luc, Dalle Frédéric, Menotti Jean, Aubert Dominique, Franck Jacqueline, Bessières Marie-Hélène, Quinio Dorothée, Pelloux Hervé, Delhaes Laurence, Desbois Nicole, Thulliez Philippe, Robert-Gangneux Florence, Kauffmann-Lacroix Catherine, Pujol Sophie, Rabodonirina Meja, Bougnoux Marie-Elisabeth, Cuisenier Bernadette, Duhamel Chantal, Duong Thanh Hai, Filisetti Denis, Flori Pierre, Gay-Andrieu Françoise, Pratlong Francine, Nevez Gilles, Totet Anne, Carme Bernard, Bonnabau Henri, Dardé Marie-Laure, Villena Isabelle

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

We report the genotyping analysis of Toxoplasma gondii isolates in samples collected from 88 immunocompromised patients, along with clinical and epidemiological data. Most of these samples were collected in France during the current decade by the Toxoplasma Biological Resource Center. Lack of specific anti-Toxoplasma treatment, pulmonary toxoplasmosis, and involvement of multiple organs were the 3 main risk factors associated with death for this patient group. Genotyping results with 6 microsatellite markers showed that type II isolates were predominant among patients who acquired toxoplasmic infection in Europe. Non-type II isolates included 13 different genotypes and were mainly collected from patients who acquired toxoplasmosis outside Europe. Type III was the second most common genotype recovered from patients, whereas type I was rare in our population. Three nonarchetypal genotypes were repeatedly recovered from different patients who acquired the infection in sub-Saharan Africa (genotypes Africa 1 and Africa 2) and in the French West Indies (genotype Caribbean 1). The distribution of genotypes (type II vs. non-type II) was not significantly different when patients were stratified by underlying cause of immunosuppression, site of infection, or outcome. We conclude that in immunocompromised patients, host factors are much more involved than parasite factors in patients' resistance or susceptibility to toxoplasmosis.

Для цитирования: Ajzenberg Daniel, Yera Hélène, Marty Pierre, Paris Luc, Dalle Frédéric, Menotti Jean, Aubert Dominique, Franck Jacqueline, Bessières Marie-Hélène, Quinio Dorothée, Pelloux Hervé, Delhaes Laurence, Desbois Nicole, Thulliez Philippe, Robert-Gangneux Florence, Kauffmann-Lacroix Catherine, Pujol Sophie, Rabodonirina Meja, Bougnoux Marie-Elisabeth, Cuisenier Bernadette, Duhamel Chantal, Duong Thanh Hai, Filisetti Denis, Flori Pierre, Gay-Andrieu Françoise, Pratlong Francine, Nevez Gilles, Totet Anne, Carme Bernard, Bonnabau Henri, Dardé Marie-Laure, Villena Isabelle. Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings.. The Journal of infectious diseases. 2009. DOI: 10.1086/597477.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.